INTRODUCTION:@0.084848:0.038601:0.257498:0.038601:0.257498:0.019343:0.084848:0.019343:0.005315:0.017404:0.010019:0.014276:0.020438:0.017498:0.015405:0.019121:0.010019:0.005315:0.020438:0.017404
6:@0.028974:0.038809:0.039510:0.038809:0.039510:0.019212:0.028974:0.019212:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
12.  Jeremic B, Vanderpuye V, Abdel-Wahab S,:@0.084242:0.094740:0.475137:0.094740:0.475137:0.080735:0.084242:0.080735:0.009476:0.009476:0.004738:0.012657:0.000000:0.008244:0.011118:0.005075:0.011118:0.016044:0.003421:0.011067:0.005148:0.009818:0.004738:0.005148:0.010232:0.011682:0.010434:0.011716:0.011118:0.005148:0.011665:0.010399:0.009168:0.011118:0.005148:0.010198:0.004738:0.005148:0.012657:0.011665:0.011716:0.011118:0.003421:0.005679:0.015572:0.011682:0.010434:0.011682:0.011665:0.005148:0.008518:0.004738
et  al:@0.120589:0.108874:0.159989:0.108874:0.159989:0.094869:0.120589:0.094869:0.011118:0.005798:0.004738:0.002643:0.011682:0.003421
. Patterns of practice in palliative ra-:@0.159989:0.108874:0.475163:0.108874:0.475163:0.094869:0.159989:0.094869:0.004738:0.007389:0.010126:0.011682:0.005798:0.005798:0.011118:0.005499:0.010434:0.006636:0.007389:0.011203:0.005371:0.007389:0.011665:0.005148:0.011682:0.011067:0.005798:0.003421:0.011067:0.011118:0.007389:0.003421:0.010434:0.007389:0.011665:0.011682:0.003421:0.003421:0.003421:0.011682:0.005798:0.003421:0.009476:0.011118:0.007389:0.005148:0.011682:0.005679
diotherapy  in  Africa  –  case  revisited. :@0.120589:0.121974:0.440824:0.121974:0.440824:0.107969:0.120589:0.107969:0.011716:0.003421:0.011203:0.005798:0.010434:0.011118:0.005148:0.011682:0.011665:0.009168:0.004738:0.003134:0.003421:0.010434:0.004738:0.003135:0.012657:0.005371:0.005148:0.003421:0.011067:0.011682:0.004738:0.003134:0.008552:0.004738:0.003135:0.011067:0.011682:0.006636:0.011118:0.004738:0.003139:0.005078:0.011118:0.009476:0.003421:0.006636:0.003421:0.005798:0.011118:0.011716:0.004738:0.004738
Clin:@0.443971:0.121974:0.475152:0.121974:0.475152:0.107969:0.443971:0.107969:0.013906:0.003421:0.003421:0.010434
Oncol (R Coll Radiol).:@0.120589:0.135074:0.297311:0.135074:0.297311:0.121069:0.120589:0.121069:0.014864:0.010434:0.011067:0.011203:0.003421:0.004738:0.006312:0.010382:0.004738:0.013906:0.011203:0.003421:0.003421:0.004738:0.010382:0.011682:0.011716:0.003421:0.011203:0.003421:0.006312:0.004738
 2014;26:333-43.:@0.297311:0.135074:0.426176:0.135074:0.426176:0.121069:0.297311:0.121069:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
13    International Union  Against Cancer:  WHO :@0.084242:0.148174:0.479882:0.148174:0.479882:0.134169:0.084242:0.134169:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.003866:0.010434:0.005798:0.011118:0.005490:0.010434:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.007475:0.011203:0.010434:0.003421:0.011203:0.010434:0.004738:0.002728:0.012657:0.011511:0.011682:0.003421:0.010434:0.006636:0.005798:0.007475:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738:0.004738:0.002726:0.016420:0.011682:0.014864:0.784246
Essential  Medicines List  http://www.uicc.:@0.120572:0.161274:0.475139:0.161274:0.475139:0.147268:0.120572:0.147268:0.009168:0.006636:0.006636:0.011118:0.010434:0.005798:0.003421:0.011682:0.003421:0.004738:0.007399:0.015719:0.011118:0.011716:0.003421:0.011067:0.003421:0.010434:0.011118:0.006636:0.012127:0.007902:0.003421:0.006636:0.005798:0.004738:0.007389:0.010434:0.005798:0.005798:0.011665:0.004738:0.007475:0.007475:0.014214:0.014214:0.014214:0.004738:0.010399:0.003421:0.011067:0.011067:0.004738
org/who-essential-medicines-list. Accessed :@0.120572:0.174373:0.479866:0.174373:0.479866:0.160368:0.120572:0.160368:0.011203:0.005148:0.011511:0.007475:0.014214:0.010434:0.011203:0.005679:0.011118:0.006636:0.006636:0.011118:0.010434:0.005798:0.003421:0.011682:0.003421:0.005679:0.016044:0.011118:0.011716:0.003421:0.011067:0.003421:0.010434:0.011118:0.006636:0.005679:0.003421:0.003421:0.006636:0.005815:0.004738:0.005046:0.012657:0.011067:0.011067:0.011118:0.006636:0.006636:0.011118:0.011716:0.004738
January 2018.:@0.120572:0.187473:0.234709:0.187473:0.234709:0.173468:0.120572:0.173468:0.008244:0.011682:0.010434:0.010399:0.011682:0.005148:0.009168:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738
14.  Martei Y, Binagwaho A, Shulman L, :@0.084225:0.200573:0.407197:0.200573:0.407197:0.186568:0.084225:0.186568:0.009476:0.009476:0.004738:0.012674:0.000000:0.015719:0.011682:0.005148:0.005798:0.011118:0.003421:0.004088:0.008462:0.004738:0.004088:0.009818:0.003421:0.010434:0.011682:0.011511:0.014214:0.011682:0.010434:0.011203:0.004076:0.012657:0.004738:0.004078:0.008518:0.010434:0.010399:0.003421:0.016044:0.011682:0.010434:0.004088:0.007902:0.004738:0.780714
et al:@0.406523:0.200573:0.442621:0.200573:0.442621:0.186568:0.406523:0.186568:0.011118:0.005798:0.004079:0.011682:0.003421
. Af-:@0.442621:0.200573:0.475154:0.200573:0.475154:0.186568:0.442621:0.186568:0.004738:0.004088:0.012657:0.005371:0.005679
fordability of cancer drugs in sub-Saharan:@0.120589:0.213673:0.475156:0.213673:0.475156:0.199668:0.120589:0.199668:0.005371:0.011203:0.005041:0.011716:0.011682:0.011665:0.003421:0.003421:0.003421:0.005798:0.009168:0.006481:0.011203:0.005371:0.006465:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.006465:0.011716:0.005148:0.010399:0.011511:0.006636:0.006465:0.003421:0.010434:0.006465:0.006636:0.010399:0.011665:0.005679:0.008518:0.011682:0.010434:0.011682:0.005148:0.011682:0.010434
Africa: effects of pricing on needless loss of:@0.120589:0.226773:0.475164:0.226773:0.475164:0.212767:0.120589:0.212767:0.012657:0.005371:0.005148:0.003421:0.011067:0.011682:0.004738:0.004625:0.011118:0.005419:0.005371:0.011118:0.011067:0.005798:0.006636:0.004635:0.011203:0.005371:0.004627:0.011665:0.005148:0.003421:0.011067:0.003421:0.010434:0.011511:0.004635:0.011203:0.010434:0.004625:0.010434:0.011118:0.011118:0.011716:0.003421:0.011118:0.006636:0.006636:0.004635:0.003421:0.011203:0.006636:0.006636:0.004635:0.011203:0.005371
life. :@0.120589:0.239873:0.153395:0.239873:0.153395:0.225867:0.120589:0.225867:0.003421:0.003421:0.005371:0.011118:0.004738:0.004738
JAMA Oncol:@0.153395:0.239873:0.258399:0.239873:0.258399:0.225867:0.153395:0.225867:0.008244:0.012657:0.015719:0.012657:0.004738:0.014864:0.010434:0.011067:0.011203:0.003421
. 2017;3(10):1301-1302.:@0.258382:0.239873:0.442510:0.239873:0.442510:0.225867:0.258382:0.225867:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.006312:0.009476:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.004738
15.  Rhee JY, Garralda E, Torrado C, :@0.084242:0.252972:0.391965:0.252972:0.391965:0.238967:0.084242:0.238967:0.009479:0.009479:0.004738:0.012650:0.000000:0.010211:0.010263:0.010947:0.010947:0.007218:0.008073:0.008296:0.004567:0.007218:0.014744:0.011511:0.004977:0.004977:0.011511:0.003250:0.011545:0.011511:0.007218:0.008997:0.004567:0.007218:0.006276:0.011032:0.004977:0.004977:0.011511:0.011545:0.011032:0.007218:0.013735:0.004567:0.719729
et al:@0.394445:0.252972:0.433170:0.252972:0.433170:0.238967:0.394445:0.238967:0.010947:0.005627:0.007218:0.011511:0.003421
. Pal-:@0.432999:0.252972:0.475178:0.252972:0.475178:0.238967:0.432999:0.238967:0.004567:0.007218:0.009955:0.011511:0.003250:0.005679
liative care in Africa: a scoping review from:@0.120589:0.266072:0.475140:0.266072:0.475140:0.252067:0.120589:0.252067:0.003250:0.003250:0.011511:0.005627:0.003250:0.009305:0.010947:0.005131:0.010895:0.011511:0.004907:0.010947:0.005131:0.003250:0.010263:0.005131:0.012486:0.005200:0.004977:0.003250:0.010895:0.011511:0.004567:0.005131:0.011511:0.005131:0.006465:0.010895:0.011032:0.011494:0.003250:0.010263:0.011340:0.005131:0.004907:0.010947:0.009305:0.003250:0.010947:0.014043:0.005131:0.005200:0.004907:0.011032:0.016044
2005-16. :@0.120589:0.279172:0.191230:0.279172:0.191230:0.265167:0.120589:0.265167:0.009305:0.009305:0.009305:0.009305:0.005508:0.009305:0.009305:0.004567:0.004738
Lancet Oncol.:@0.190974:0.279172:0.307275:0.279172:0.307275:0.265167:0.190974:0.265167:0.007731:0.011511:0.010263:0.010895:0.010947:0.005627:0.004456:0.014693:0.010263:0.010895:0.011032:0.003250:0.004738
 2017;18(9):522-e531.:@0.307104:0.279172:0.475127:0.279172:0.475127:0.265167:0.307104:0.265167:0.004454:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.009305:0.006140:0.009305:0.006140:0.004567:0.009305:0.009305:0.009305:0.005508:0.010947:0.009305:0.009305:0.009305:0.004738
16.   World Health Organization. WHA67.19 –:@0.084242:0.292272:0.475152:0.292272:0.475152:0.278267:0.084242:0.278267:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.015633:0.011203:0.005148:0.003421:0.011716:0.012435:0.011682:0.011118:0.011682:0.003421:0.005798:0.010434:0.012435:0.014864:0.005164:0.011511:0.011682:0.010434:0.003421:0.007269:0.011682:0.005798:0.003421:0.011203:0.010434:0.004729:0.012435:0.016420:0.011682:0.012657:0.009476:0.009476:0.004738:0.009476:0.009476:0.012435:0.583193
Strengthening of palliative care as a com-:@0.120589:0.306406:0.475169:0.306406:0.475169:0.292401:0.120589:0.292401:0.008518:0.005798:0.005077:0.011118:0.010434:0.011511:0.005798:0.010434:0.011118:0.010434:0.003421:0.010434:0.011511:0.005706:0.011203:0.005371:0.005730:0.011665:0.011682:0.003421:0.003421:0.003431:0.011682:0.005798:0.003421:0.009476:0.011118:0.005730:0.011067:0.011682:0.005078:0.011118:0.005721:0.011682:0.006636:0.005730:0.011682:0.005730:0.011067:0.011203:0.016044:0.005679
ponent  of comprehensive care through-:@0.120589:0.320541:0.475145:0.320541:0.475145:0.306536:0.120589:0.306536:0.011665:0.011203:0.010434:0.011118:0.010434:0.005798:0.004738:0.005020:0.011203:0.005371:0.009767:0.011067:0.011203:0.016044:0.011665:0.005077:0.011118:0.010434:0.011118:0.010434:0.006636:0.003421:0.009476:0.011118:0.009767:0.011067:0.011682:0.005078:0.011118:0.009767:0.005798:0.010434:0.005073:0.011203:0.010399:0.011511:0.010420:0.005679
out the life course. WHA Resolution; Sixty-:@0.120589:0.334676:0.475154:0.334676:0.475154:0.320670:0.120589:0.320670:0.011203:0.010399:0.005798:0.007646:0.005798:0.010434:0.011118:0.007646:0.003421:0.003421:0.005371:0.011118:0.007646:0.011067:0.011203:0.010399:0.005140:0.006636:0.011118:0.004738:0.007646:0.016420:0.011682:0.012657:0.007646:0.010382:0.011118:0.006636:0.011203:0.003421:0.010399:0.005798:0.003421:0.011203:0.010434:0.004738:0.007646:0.008518:0.003421:0.008210:0.005798:0.009168:0.005679
seventh World Health Assembly, 2014.:@0.120589:0.348810:0.475147:0.348810:0.475147:0.334805:0.120589:0.334805:0.006636:0.011118:0.009476:0.011118:0.010434:0.005798:0.010434:0.015890:0.015635:0.011203:0.005148:0.003421:0.011716:0.015890:0.011682:0.011118:0.011682:0.003421:0.005798:0.010434:0.015890:0.012657:0.006636:0.006636:0.011118:0.016044:0.011665:0.003421:0.009168:0.004738:0.015890:0.009476:0.009476:0.009476:0.009476:0.004738
http://apps.who.int/medicinedocs/en/d/:@0.120589:0.362945:0.462728:0.362945:0.462728:0.348940:0.120589:0.348940:0.010434:0.005798:0.005798:0.011665:0.004738:0.007475:0.007475:0.011682:0.011665:0.011665:0.006636:0.004738:0.014214:0.010434:0.011203:0.004738:0.003421:0.010434:0.005798:0.007475:0.016044:0.011118:0.011716:0.003421:0.011067:0.003421:0.010434:0.011118:0.011716:0.011203:0.011067:0.006636:0.007475:0.011118:0.010434:0.007475:0.011716:0.007475
Js21454ar/. Accessed January 2018.:@0.120589:0.377080:0.417538:0.377080:0.417538:0.363074:0.120589:0.363074:0.008244:0.006636:0.009476:0.009476:0.009476:0.009476:0.009476:0.011682:0.005148:0.007492:0.004738:0.004738:0.012657:0.011067:0.011067:0.011118:0.006636:0.006636:0.011118:0.011716:0.004738:0.008244:0.011682:0.010434:0.010399:0.011682:0.005148:0.009168:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738
17.  Spearman W, Afihene M, Ally R, :@0.523636:0.094775:0.826170:0.094775:0.826170:0.080770:0.523636:0.080770:0.009476:0.009476:0.004738:0.012657:0.000000:0.008518:0.011665:0.011118:0.011682:0.005627:0.016044:0.011682:0.010434:0.005403:0.014607:0.004738:0.005402:0.012657:0.004165:0.004165:0.010434:0.011118:0.010434:0.011118:0.005390:0.015719:0.004738:0.005400:0.012657:0.003421:0.003421:0.009168:0.005405:0.010382:0.004738:0.515629
et al:@0.826828:0.094775:0.864253:0.094775:0.864253:0.080770:0.826828:0.080770:0.011118:0.005798:0.005405:0.011682:0.003421
. Hep-:@0.864253:0.094775:0.914539:0.094775:0.914539:0.080770:0.864253:0.080770:0.004738:0.005405:0.011682:0.011118:0.011665:0.005679
atitis B in sub-Saharan Africa: strategies to:@0.559983:0.109639:0.914548:0.109639:0.914548:0.095633:0.559983:0.095633:0.011682:0.005798:0.003421:0.005798:0.003421:0.006636:0.006705:0.009818:0.006705:0.003421:0.010434:0.006705:0.006636:0.010399:0.011665:0.005679:0.008518:0.011682:0.010434:0.011682:0.005148:0.011682:0.010434:0.006705:0.012657:0.005371:0.005148:0.003421:0.011067:0.011682:0.004738:0.006696:0.006636:0.005798:0.005148:0.011682:0.005798:0.011118:0.011511:0.003421:0.011118:0.006636:0.006705:0.005798:0.011203
achieve the  2030 elimination targets. :@0.559983:0.124502:0.882599:0.124502:0.882599:0.110497:0.559983:0.110497:0.011682:0.011067:0.010434:0.003421:0.011118:0.009476:0.011118:0.007868:0.005798:0.010434:0.011118:0.004738:0.003118:0.009476:0.009476:0.009486:0.009476:0.007868:0.011118:0.003421:0.003421:0.016044:0.003421:0.010434:0.011682:0.005798:0.003421:0.011203:0.010434:0.007868:0.005798:0.011682:0.005160:0.011511:0.011118:0.005798:0.006636:0.004738:0.004738
The:@0.885719:0.124502:0.914556:0.124502:0.914556:0.110497:0.885719:0.110497:0.007286:0.010434:0.011118
Lancet Gastroenterology  & Hepatology:@0.559983:0.139366:0.909825:0.139366:0.909825:0.125361:0.559983:0.125361:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798:0.011648:0.014915:0.011682:0.006636:0.005798:0.005148:0.011203:0.011118:0.010434:0.005798:0.011118:0.005148:0.011203:0.003421:0.011203:0.011511:0.009168:0.004738:0.006900:0.012948:0.011648:0.011682:0.011118:0.011665:0.011682:0.005798:0.011203:0.003421:0.011203:0.011511:0.009168
.:@0.909825:0.139366:0.914563:0.139366:0.914563:0.125361:0.909825:0.125361:0.004738
2017;2:(12):900-909.:@0.559983:0.154230:0.720422:0.154230:0.720422:0.140225:0.559983:0.140225:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.006312:0.009476:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
18.  Dochez  C, Burnett  R, Mbassi S, :@0.523636:0.169094:0.831903:0.169094:0.831903:0.155088:0.523636:0.155088:0.009476:0.009476:0.004738:0.012657:0.000000:0.012726:0.011203:0.011067:0.010434:0.011118:0.007269:0.004738:0.003592:0.013906:0.004738:0.008347:0.009818:0.010399:0.005502:0.010434:0.011118:0.005798:0.005798:0.004738:0.003599:0.010382:0.004738:0.008347:0.015719:0.011665:0.011682:0.006636:0.006647:0.003421:0.008347:0.008518:0.004738:0.401796
et al:@0.835512:0.169094:0.875878:0.169094:0.875878:0.155088:0.835512:0.155088:0.011118:0.005798:0.008347:0.011682:0.003421
. Im-:@0.875878:0.169094:0.914551:0.169094:0.914551:0.155088:0.875878:0.155088:0.004738:0.008347:0.003866:0.016044:0.005679
proving skills  and institutional capacity to:@0.559983:0.183957:0.914553:0.183957:0.914553:0.169952:0.559983:0.169952:0.011665:0.005080:0.011203:0.009476:0.003421:0.010434:0.011511:0.008279:0.006636:0.008586:0.003421:0.003421:0.003421:0.006636:0.004738:0.003554:0.011682:0.010434:0.011716:0.008279:0.003421:0.010434:0.006636:0.005798:0.003421:0.005798:0.010399:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.008279:0.011067:0.011682:0.011665:0.011682:0.011067:0.003421:0.005798:0.009168:0.008279:0.005798:0.011203
strengthen  adolescent immunisation pro-:@0.559983:0.198821:0.914543:0.198821:0.914543:0.184816:0.559983:0.184816:0.006636:0.005798:0.005078:0.011118:0.010434:0.011511:0.005798:0.010434:0.011118:0.010434:0.004738:0.005068:0.011682:0.011716:0.011203:0.003421:0.011118:0.006636:0.011067:0.011118:0.010434:0.005798:0.009818:0.003421:0.016044:0.016044:0.010399:0.010434:0.003421:0.006636:0.011682:0.005798:0.003421:0.011203:0.010434:0.009818:0.011665:0.005080:0.011203:0.005679
grammes and health systems  in African:@0.559983:0.213685:0.914534:0.213685:0.914534:0.199679:0.559983:0.199679:0.011511:0.005148:0.011682:0.016044:0.016044:0.011118:0.006636:0.010793:0.011682:0.010434:0.011716:0.010793:0.010434:0.011118:0.011682:0.003421:0.005798:0.010434:0.010793:0.006636:0.009168:0.006636:0.005798:0.011118:0.016044:0.006636:0.004738:0.006067:0.003421:0.010434:0.010793:0.012657:0.005371:0.005148:0.003421:0.011067:0.011682:0.010434
countries  through HPV vaccine introduc-:@0.559983:0.228548:0.914546:0.228548:0.914546:0.214543:0.559983:0.214543:0.011067:0.011203:0.010399:0.010434:0.005798:0.005148:0.003421:0.011118:0.006636:0.004738:0.004661:0.005798:0.010434:0.005073:0.011203:0.010399:0.011503:0.010434:0.009407:0.011682:0.010126:0.012007:0.009407:0.009476:0.011682:0.011067:0.011067:0.003421:0.010434:0.011118:0.009407:0.003421:0.010434:0.005798:0.005077:0.011203:0.011716:0.010399:0.011067:0.005679
tion. :@0.559983:0.243412:0.600315:0.243412:0.600315:0.229407:0.559983:0.229407:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738
Papillomavirus Research.:@0.600418:0.243412:0.805328:0.243412:0.805328:0.229407:0.600418:0.229407:0.010126:0.011682:0.011665:0.003421:0.003421:0.003421:0.011203:0.016044:0.011682:0.009476:0.003421:0.005148:0.010399:0.006636:0.004841:0.010382:0.011118:0.006636:0.011118:0.011682:0.005148:0.011067:0.010434:0.004738
 2017;4: 2017::@0.805328:0.243412:0.914505:0.243412:0.914505:0.229407:0.805328:0.229407:0.004841:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.004841:0.009476:0.009476:0.009476:0.009476:0.004738
66-71.:@0.559983:0.258276:0.608303:0.258276:0.608303:0.244271:0.559983:0.244271:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
19.   Nyamurungi K, Olakira S, Kadobera D, :@0.523636:0.273140:0.874447:0.273140:0.874447:0.259134:0.523636:0.259134:0.009476:0.009476:0.004738:0.012657:0.004738:-0.004738:0.012657:0.009168:0.011682:0.016044:0.010399:0.005148:0.010399:0.010434:0.011511:0.003421:0.004020:0.010109:0.004738:0.004037:0.014864:0.003421:0.011682:0.008586:0.003421:0.005148:0.011682:0.004037:0.008518:0.004738:0.004037:0.010109:0.011682:0.011716:0.011203:0.011665:0.011118:0.005148:0.011682:0.004037:0.012726:0.004738:0.207913
et al:@0.873745:0.273140:0.909801:0.273140:0.909801:0.259134:0.873745:0.259134:0.011118:0.005798:0.004037:0.011682:0.003421
.:@0.909801:0.273140:0.914539:0.273140:0.914539:0.259134:0.909801:0.259134:0.004738
The health cost of tobacco use in Uganda.:@0.559966:0.288003:0.914556:0.288003:0.914556:0.273998:0.559966:0.273998:0.007286:0.010434:0.011118:0.004704:0.010434:0.011118:0.011682:0.003421:0.005798:0.010434:0.004704:0.011067:0.011203:0.006636:0.005798:0.004704:0.011203:0.005371:0.004704:0.005798:0.011203:0.011665:0.011682:0.011067:0.011067:0.011203:0.004704:0.010399:0.006636:0.011118:0.004704:0.003421:0.010434:0.004704:0.011203:0.011511:0.011682:0.010434:0.011716:0.011682:0.004738
Health  Policy and  Planning.:@0.559966:0.302867:0.796588:0.302867:0.796588:0.288862:0.559966:0.288862:0.011682:0.011118:0.011682:0.003421:0.005798:0.010434:0.004738:0.003275:0.010126:0.011203:0.003421:0.003421:0.011067:0.009168:0.008022:0.011682:0.010434:0.011716:0.004738:0.003275:0.010126:0.003421:0.011682:0.010434:0.010434:0.003421:0.010434:0.011511:0.004738
  2017;32:1153-:@0.796588:0.302867:0.914527:0.302867:0.914527:0.288862:0.796588:0.288862:0.004738:0.003275:0.009476:0.009476:0.009476:0.009489:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679
1160.:@0.559966:0.317731:0.602607:0.317731:0.602607:0.303725:0.559966:0.303725:0.009476:0.009476:0.009476:0.009476:0.004738
20.  The PLOS Medicine Editors. Tobacco con-:@0.523619:0.332594:0.914563:0.332594:0.914563:0.318589:0.523619:0.318589:0.009476:0.009476:0.004738:0.012674:0.000000:0.007286:0.010434:0.011118:0.007150:0.010126:0.007902:0.014864:0.008518:0.007153:0.015719:0.011118:0.011716:0.003421:0.011067:0.003421:0.010434:0.011118:0.007167:0.009168:0.011716:0.003421:0.005798:0.011203:0.005148:0.006636:0.004738:0.007153:0.006447:0.011203:0.011665:0.011682:0.011067:0.011067:0.011203:0.007151:0.011067:0.011203:0.010434:0.082258
trol:  developing  an  innovative and  effec-:@0.559983:0.347458:0.914551:0.347458:0.914551:0.333453:0.559983:0.333453:0.005798:0.005077:0.011203:0.003421:0.004738:0.004738:0.002672:0.011716:0.011118:0.009476:0.011118:0.003421:0.011203:0.011665:0.003421:0.010434:0.011511:0.004738:0.002673:0.011682:0.010434:0.004738:0.002673:0.003421:0.010434:0.010434:0.011203:0.009476:0.011682:0.005798:0.003421:0.009476:0.011118:0.007423:0.011682:0.010434:0.011716:0.004738:0.002673:0.011118:0.005419:0.005371:0.011118:0.011067:0.005679
tive global strategy. :@0.559983:0.362322:0.731146:0.362322:0.731146:0.348316:0.559983:0.348316:0.005798:0.003421:0.009476:0.011118:0.006055:0.011511:0.003421:0.011203:0.011665:0.011682:0.003421:0.006055:0.006636:0.005798:0.005148:0.011682:0.005798:0.011118:0.011511:0.009168:0.004738:0.004738
PLOS Medicine.:@0.732463:0.362322:0.862679:0.362322:0.862679:0.348316:0.732463:0.348316:0.010126:0.007902:0.014864:0.008518:0.006055:0.015719:0.011118:0.011716:0.003421:0.011067:0.003421:0.010434:0.011118:0.004738
 14(5)::@0.862679:0.362322:0.914522:0.362322:0.914522:0.348316:0.862679:0.348316:0.006055:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738
e1002308.:@0.559983:0.377185:0.642170:0.377185:0.642170:0.363180:0.559983:0.363180:0.011118:0.009476:0.009476:0.009476:0.009476:0.009476:0.009476:0.009476:0.004738